A new trading day began on Monday, with Seres Therapeutics Inc (NASDAQ: MCRB) stock price down -0.70% from the previous day of trading, before settling in for the closing price of $0.70. MCRB’s price has ranged from $0.54 to $2.05 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 386.36% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 11.81%. With a float of $118.98 million, this company’s outstanding shares have now reached $135.04 million.
In an organization with 233 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -1918.98%, operating margin of -43457.49%, and the pretax margin is -43343.58%.
Seres Therapeutics Inc (MCRB) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Seres Therapeutics Inc is 30.10%, while institutional ownership is 27.24%. The most recent insider transaction that took place on Aug 16 ’24, was worth 733. In this transaction Chief Legal Officer and EVP of this company sold 873 shares at a rate of $0.84, taking the stock ownership to the 124,173 shares. Before that another transaction happened on Aug 16 ’24, when Company’s See Remarks sold 973 for $0.84, making the entire transaction worth $817. This insider now owns 21,013 shares in total.
Seres Therapeutics Inc (MCRB) Performance Highlights and Predictions
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.37 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.81% per share during the next fiscal year.
Seres Therapeutics Inc (NASDAQ: MCRB) Trading Performance Indicators
Here are Seres Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 322.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.55 in one year’s time.
Technical Analysis of Seres Therapeutics Inc (MCRB)
Let’s dig in a bit further. During the last 5-days, its volume was 2.04 million. That was inferior than the volume of 4.44 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 9.55%. Additionally, its Average True Range was 0.08.
During the past 100 days, Seres Therapeutics Inc’s (MCRB) raw stochastic average was set at 14.13%, which indicates a significant increase from 10.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.90% in the past 14 days, which was lower than the 132.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8879, while its 200-day Moving Average is $0.9422. However, in the short run, Seres Therapeutics Inc’s stock first resistance to watch stands at $0.7433. Second resistance stands at $0.7867. The third major resistance level sits at $0.8133. If the price goes on to break the first support level at $0.6733, it is likely to go to the next support level at $0.6467. Assuming the price breaks the second support level, the third support level stands at $0.6033.
Seres Therapeutics Inc (NASDAQ: MCRB) Key Stats
With a market capitalization of 119.14 million, the company has a total of 151,448K Shares Outstanding. Currently, annual sales are 126,330 K while annual income is -113,720 K. The company’s previous quarter sales were 0 K while its latest quarter income was -40,130 K.
